Overview
Corporate Profile
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need.
Copyright West LLC. Minimum 15 minutes delayed.
Latest News
View All
Mar 02, 2020
Gamida Cell Announces Updated Data from Phase 1 Study of GDA-201 to be Presented at the Annual Meeting of the European Society for Blood and Marrow Transplantation
Read More
Feb 25, 2020
Gamida Cell Reports Full Year 2019 Financial Results and Provides Company Update
Read More
Feb 19, 2020
Gamida Cell Announces the Date of Its Full Year 2019 Financial Results and Webcast
Read More
Jan 02, 2020
Gamida Cell Announces Completion of Patient Enrollment in Ongoing Phase 3 Clinical Study of Omidubicel
Read More
Dec 09, 2019
Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting
Read More
Nov 21, 2019
Gamida Cell to Present at the 31st Annual Piper Jaffray Healthcare Conference
Read More
Nov 13, 2019
Gamida Cell Reports Third Quarter 2019 Financial Results and Provides Company Update
Read More
Nov 05, 2019
Gamida Cell Announces the Date of Its Third Quarter 2019 Financial Results and Webcast
Read More
Sep 11, 2019
Gamida Cell and the CIBMTR Announce Collaboration to Advance Research for Life-Saving Cellular Therapy
Read More
Aug 06, 2019
Gamida Cell Reports Second Quarter 2019 Financial Results and Provides Company Update
Read More
Jul 23, 2019
Gamida Cell Announces the Date of Its Second Quarter 2019 Financial Results and Webcast
Read More
Jul 08, 2019
Gamida Cell Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
Read More
Jun 26, 2019
Gamida Cell Announces Pricing of $35 Million Public Offering of Ordinary Shares
Read More
Jun 19, 2019
Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel
Read More
Jun 05, 2019
Gamida Cell Bolsters Management Team with Appointment of Tracey Lodie, Ph.D., as Chief Scientific Officer
Read More
May 31, 2019
Gamida Cell Announces Data for Omidubicel Presented at the International Society for Cellular and Gene Therapy 2019 Annual Meeting
Read More
Upcoming Events
More events are coming soon.
Recent Events
Corporate Fact Sheet
Corporate Presentation
Investor & Media Contact
Jaren Irene Madden
Vice President of Investor Relations and Corporate Communications
Gamida Cell Ltd.
IRPR@gamida-cell.com